No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds.

Albendazole / therapeutic use Animals Cross-Sectional Studies Elephantiasis, Filarial / drug therapy Filaricides / therapeutic use Humans Immunoglobulin G Ivermectin / therapeutic use Mass Drug Administration Microfilariae Mosquito Vectors Prevalence Wuchereria bancrofti
Anopheles gambiae complex Lymphatic filariasis Mali Mass drug administration Sudan savannah area Vector collection methods

Journal

Parasitology research
ISSN: 1432-1955
Titre abrégé: Parasitol Res
Pays: Germany
ID NLM: 8703571

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 22 03 2022
accepted: 30 08 2022
pubmed: 7 9 2022
medline: 15 10 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Lymphatic filariasis (LF) elimination activities started in Mali in 2005 in the most endemic areas and reached countrywide coverage in 2009. In 2004, the district of Bamako was endemic for LF with a prevalence of 1.5%. The current study was designed to determine LF endemicity level in the urban area of Bamako after three rounds of ivermectin and albendazole mass drug administration (MDA). A cross-sectional study was conducted in 2011 in Bamako city, consisting of human prevalence and entomological surveys. Volunteers aged 14 years and above were invited to participate and tested for evidence of Wuchereria bancrofti using night time blood thick smear microfilarial count and blood spots for LF antibodies using the SD BIOLINE Oncho/LF IgG4 Biplex rapid test (Ov16/Wb123). Mosquitoes were collected using CDC light and gravid traps and tested using molecular methods. Poolscreen software v2.0 was used to estimate vector transmission potential. Of the 899 volunteers, one (0.11%) was found to be positive for LF using the Oncho/LF IgG4 Biplex rapid test, and none was found to have Wuchereria bancrofti microfilariae. No mosquitoes were found infected among 6174 Culex spp. (85.2%), 16 Anopheles gambiae s.l. (An. gambiae s.l.) (0.2%), 26 Aedes spp. (0.4%), 858 Ceratopogonidae (11.8%) and 170 other insects not identified (2.3%) tested. Our data indicate that there was no active LF transmission in the low prevalence urban district of Bamako after three MDA rounds. These data helped the National LF programme move forward towards the elimination goal.

Identifiants

DOI: 10.1007/s00436-022-07648-8 PMID: 36066741 PMC: PMC9556341
pubmed: 36066741
doi: 10.1007/s00436-022-07648-8
pii: 10.1007/s00436-022-07648-8
pmc: PMC9556341
doi:

Substances chimiques

Filaricides 0
Immunoglobulin G 0
Ivermectin 70288-86-7
Albendazole F4216019LN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3243-3248

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Adams AM et al (2018) Eliminating neglected tropical diseases in urban areas: a review of challenges, strategies and research directions for successful mass drug administration. Trop Med Infect Dis 3(4). https://doi.org/10.3390/tropicalmed3040122
Bockarie MJ, Pedersen EM, White GB, Michael E (2009) Role of vector control in the global program to eliminate lymphatic filariasis. Annu Rev Entomol 54:469–487. https://doi.org/10.1146/annurev.ento.54.110807.090626
doi: 10.1146/annurev.ento.54.110807.090626 pubmed: 18798707
Cano J et al (2014) The global distribution and transmission limits of lymphatic filariasis: past and present. Parasit Vectors 7:466. https://doi.org/10.1186/s13071-014-0466-x
doi: 10.1186/s13071-014-0466-x pubmed: 25303991 pmcid: 4197264
Castro MC, Kanamori S, Kannady K, Mkude S, Killeen GF, Fillinger U (2010) The importance of drains for the larval development of lymphatic filariasis and malaria vectors in Dar es Salaam, United Republic of Tanzania. PLoS Negl Trop Dis 4(5):e693. https://doi.org/10.1371/journal.pntd.0000693
doi: 10.1371/journal.pntd.0000693 pubmed: 20520797 pmcid: 2876116
Chu BK et al (2013) Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl Trop Dis 7(12):e2584. https://doi.org/10.1371/journal.pntd.0002584
doi: 10.1371/journal.pntd.0002584 pubmed: 24340120 pmcid: 3855047
Cook DAN, Pilotte N, Minetti C, Williams SA, Reimer LJ (2017) A superhydrophobic cone to facilitate the xenomonitoring of filarial parasites, malaria, and trypanosomes using mosquito excreta/feces. Gates Open Res 1:7. https://doi.org/10.12688/gatesopenres.12749.2
doi: 10.12688/gatesopenres.12749.2 pubmed: 29377042
Coulibaly YI et al (2016) Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali. Parasit Vectors 9(1):628. https://doi.org/10.1186/s13071-016-1911-9
doi: 10.1186/s13071-016-1911-9 pubmed: 27912789 pmcid: 5135747
Coulibaly YI, Dao S, Traore AK, Diallo A, Sacko M, Traoré SF (2006) Presence and risk of transmission of Wuchereria bancrofti is a reality in rural Mali: the case of the town of Bariambani in the Cirle of Kati. Mali Med 21(1):12–17
pubmed: 17390523
Coulibaly YI et al (2015) The impact of six annual rounds of mass drug administration on Wuchereria bancrofti Infections in humans and in mosquitoes in Mali. Am J Trop Med Hyg 93(2):356–360. https://doi.org/10.4269/ajtmh.14-0516
doi: 10.4269/ajtmh.14-0516 pubmed: 26033027 pmcid: 4530761
Curtis CF et al (1983) Susceptibility of aposymbiotic Culex quinquefasciatus to Wuchereria bancrofti. J Invertebr Pathol 41(2):214–223. https://doi.org/10.1016/0022-2011(83)90221-5
doi: 10.1016/0022-2011(83)90221-5 pubmed: 6404991
Curtis CF, Kihamia CM, Ramji BD (1981) Tests of susceptibility of Liberian Culex quinquefasciatus to Tanzanian Wuchereria bancrofti. Trans R Soc Trop Med Hyg 75(5):736–739. https://doi.org/10.1016/0035-9203(81)90166-8
doi: 10.1016/0035-9203(81)90166-8 pubmed: 7036433
Dahan-Moss Y et al (2020) Member species of the Anopheles gambiae complex can be misidentified as Anopheles leesoni. Malar J 19(1):89. https://doi.org/10.1186/s12936-020-03168-x
doi: 10.1186/s12936-020-03168-x pubmed: 32093677 pmcid: 7038563
de Souza DK, Koudou B, Kelly-Hope LA, Wilson MD, Bockarie MJ, Boakye DA (2012) Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis. Parasit Vectors 5:259. https://doi.org/10.1186/1756-3305-5-259
doi: 10.1186/1756-3305-5-259 pubmed: 23151383 pmcid: 3533928
de Souza DK et al (2014) No evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and Liberia. PLoS Negl Trop Dis 8(2):e2700. https://doi.org/10.1371/journal.pntd.0002700
doi: 10.1371/journal.pntd.0002700 pubmed: 24516686 pmcid: 3916318
Dembélé M et al (2012) Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis 6(3):e1574. https://doi.org/10.1371/journal.pntd.0001574
doi: 10.1371/journal.pntd.0001574 pubmed: 22448294 pmcid: 3308933
Erickson SM, Fischer K, Weil GJ, Christensen BM, Fischer PU (2009) Distribution of Brugia malayi larvae and DNA in vector and non-vector mosquitoes: implications for molecular diagnostics. Parasit Vectors 2(1):56. https://doi.org/10.1186/1756-3305-2-56
doi: 10.1186/1756-3305-2-56 pubmed: 19922607 pmcid: 2781795
Farid HA, Morsy ZS, Helmy H, Ramzy RM, El Setouhy M, Weil GJ (2007) A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of lymphatic filariasis. Am J Trop Med Hyg 77(4):593–600
doi: 10.4269/ajtmh.2007.77.593 pubmed: 17978055
Fischer P et al (2007) Persistence of Brugia malayi DNA in vector and non-vector mosquitoes: implications for xenomonitoring and transmission monitoring of lymphatic filariasis. Am J Trop Med Hyg 76(3):502–507
doi: 10.4269/ajtmh.2007.76.502 pubmed: 17360875
Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG (2003) PCR and mosquito dissection as tools to monitor filarial infection levels following mass treatment. Filaria J 2(1):11. https://doi.org/10.1186/1475-2883-2-11
doi: 10.1186/1475-2883-2-11 pubmed: 12890288 pmcid: 169178
Joseph H et al (2011) Application of the filariasis CELISA antifilarial IgG(4) antibody assay in surveillance in lymphatic filariasis elimination programmes in the South Pacific. J Trop Med 2011:492023. https://doi.org/10.1155/2011/492023
doi: 10.1155/2011/492023 pubmed: 21961018 pmcid: 3180782
Katholi CR, Unnasch TR (2006) Important experimental parameters for determining infection rates in arthropod vectors using pool screening approaches. Am J Trop Med Hyg 74(5):779–785
doi: 10.4269/ajtmh.2006.74.779 pubmed: 16687680
Koudou BG et al (2018) Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary? Lancet Infect Dis 18(6):e214–e220. https://doi.org/10.1016/s1473-3099(18)30069-0
doi: 10.1016/s1473-3099(18)30069-0 pubmed: 29402636
Kuhlow F, Zielke E (1978) Dynamics and intensity of Wuchereria bancrofti transmission in the savannah and forest regions of Liberia. Tropenmed Parasitol 29(3):371–381
pubmed: 364801
Mehta PK, Rauniyar R, Gupta BP (2018) Microfilaria persistent foci during post MDA and the risk assessment of resurgence in India. Trop Med Health 46:25. https://doi.org/10.1186/s41182-018-0107-8
doi: 10.1186/s41182-018-0107-8 pubmed: 30026669 pmcid: 6050703
Mukabana WR, Takken W, Knols BG (2002) Analysis of arthropod bloodmeals using molecular genetic markers. Trends Parasitol 18(11):505–509. https://doi.org/10.1016/s1471-4922(02)02364-4
doi: 10.1016/s1471-4922(02)02364-4 pubmed: 12473367
Pichon G (2002) Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann Trop Med Parasitol 96(Suppl 2):S143–S152. https://doi.org/10.1179/000349802125002509
doi: 10.1179/000349802125002509 pubmed: 12625927
Rao RU et al (2006) A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. Am J Trop Med Hyg 74(5):826–832
doi: 10.4269/ajtmh.2006.74.826 pubmed: 16687688
Sissoko MS et al (2015) Spatial patterns of plasmodium falciparum clinical incidence, asymptomatic parasite carriage and Anopheles density in two villages in Mali. Am J Trop Med Hyg 93(4):790–797. https://doi.org/10.4269/ajtmh.14-0765
doi: 10.4269/ajtmh.14-0765 pubmed: 26324728 pmcid: 4596601
Steel C et al (2015) Rapid point-of-contact tool for mapping and integrated surveillance of Wuchereria bancrofti and Onchocerca volvulus infection. Clin Vaccine Immunol 22(8):896–901. https://doi.org/10.1128/cvi.00227-15
doi: 10.1128/cvi.00227-15 pubmed: 26018537 pmcid: 4519720
Touré YT (1979) Bio-ecologie des Anopheles (Diptera: Culicidae) dansune zone rurale de savane soudanienne au Mali village de Banambani – Arrondissement de Kati: Incidence sur la transmission du Paludisme et de la Filariose de Bancroft. PhD dissertation University of Mali/ISFRA, Bamako, Mali

Auteurs

Yaya Ibrahim Coulibaly (YI)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Dermatology Hospital of Bamako, Bamako, Mali.

Moussa Sangare (M)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali. mbsangare@icermali.org.
Interdisciplinary School of Health Sciences | Faculty of Health Sciences, University of Ottawa, Ottawa, ON, K1N 6N5, Canada. mbsangare@icermali.org.

Housseini Dolo (H)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Lamine Soumaoro (L)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Siaka Yamoussa Coulibaly (SY)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Ilo Dicko (I)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Abdoul Fatao Diabaté (AF)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Lamine Diarra (L)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Michel Emmanuel Coulibaly (ME)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Salif Seriba Doumbia (SS)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Abdallah Amadou Diallo (AA)

Mali - International Center of Excellence in Research (ICER-Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Massitan Dembele (M)

National Lymphatic Filariasis Elimination Program, Ministry of Health and Public Hygiene, Bamako, Mali.

Benjamin G Koudou (BG)

Centre Suisse de Recherche Scientifiques en Côte d'Ivoire, 01 BP 1303 Abidjan 01, Abidjan, Côte d'Ivoire.
UFR Science de la Nature, Université Nangui Abrogoua, 02 BP 801 Abidjan 01, Abidjan, Côte d'Ivoire.

Moses John Bockarie (MJ)

School of Community Health Sciences, Njala University, Bo, Sierra Leone.

Louise A Kelly-Hope (LA)

Centre for Neglected Tropical Diseases, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Amy D Klion (AD)

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Thomas B Nutman (TB)

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Benzimidazoles › Albendazole › No evidence of lymphatic filariasis...
questionsmedicales.fr › Eucaryotes › Animaux › No evidence of lymphatic filariasis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › No evidence of lymphatic filariasis...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Maladies lymphatiques › Lymphoedème › Filariose lymphatique › No evidence of lymphatic filariasis...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiparasitaires › Anthelminthiques › Antihelminthiques antinématodes › Filaricides › No evidence of lymphatic filariasis...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › No evidence of lymphatic filariasis...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Isotypes des immunoglobulines › Immunoglobuline G › No evidence of lymphatic filariasis...
questionsmedicales.fr › Composés chimiques organiques › Lactones › Ivermectine › No evidence of lymphatic filariasis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Contrôle des maladies transmissibles › Administration massive de médicament › No evidence of lymphatic filariasis...
questionsmedicales.fr › Stades d'organismes › Microfilaria › No evidence of lymphatic filariasis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Chaîne d'infection › Vecteurs de maladies › Vecteurs arthropodes › Vecteurs insectes › Vecteurs moustiques › No evidence of lymphatic filariasis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › No evidence of lymphatic filariasis...
questionsmedicales.fr › Eucaryotes › Animaux › Invertébrés › Helminthes › Nematoda › Chromadorea › Spirurida › Filarioidea › Wuchereria › Wuchereria bancrofti › No evidence of lymphatic filariasis...